Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Detox With Two Types of Treatment (BBD II)
NCT00000229Phase 2Completed
- Sponsor
- The University of Vermont
- Start
- Oct 1995
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of buprenorphine in opioid use disorder (OUD) (2 arms), sponsored by The University of Vermont. Primary endpoints: Drug use, Treatment Retention and 3 more. Started Oct 1995; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000229.